To visit the Global Nebido® website, please choose from the options below:
Explore the latest news and resources to keep you up-to-date with men's health research, events, conferences and publications.
If you are looking for scientific information on hypogonadism, testosterone therapy and testosterone related health issues then search the publications portal.
Find answers to your questions about the treatment, advantages, dosage and efficacy of using Nebido® for the long-term treatment of hypogonadism.
Access the research news archive for the latest research on testosterone deficiency and its treatment.
Copyright © 2021, Bayer AG
This website contains information on Nebido® (testosterone undecanoate) which is based on the Summary of Product Characteristics (SPC) as approved by the European Commission.
This website is intended to provide information to an international audience outside Austria, France, Germany, Hungary, Ireland, the Middle East, the Philippines, Thailand, the UK, and the USA.
Page last modified 01/04/2021
PP-NEB-ALL-0222-1 April 2021